4/A

PRIMARY DOCUMENT

Company: ENDONOVO THERAPEUTICS, INC.
Filed: April 26, 2019
Period of Report: April 22, 2019
Accession Number: 0001645470-19-000026

View Document ↗ View on SEC.gov ↗